{
    "2020-04-22": [
        [
            {
                "time": "",
                "original_text": "贝达药业一季度净利1.3亿元，同比增长152%",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "一季度",
                        "净利",
                        "同比增长",
                        "152%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业(300558.SZ)：一季度净利润升152.36%至1.3亿元",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "300558.SZ",
                        "一季度",
                        "净利润",
                        "增长",
                        "152.36%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：一季度净利润同比增长152.36%",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "一季度",
                        "净利润",
                        "同比增长",
                        "152.36%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "电鳗快报|贝达药业扣非净利润增五成 仍靠一款抗癌药“打天下”",
                "features": {
                    "keywords": [
                        "电鳗快报",
                        "贝达药业",
                        "扣非净利润",
                        "增长",
                        "五成",
                        "抗癌药"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}